Technologist Quarterly Webinar: Lutetium Lu 177 Dotatate Administration in the Nuclear Medicine Department

March 21, 2019 EDT
Event Details:

"Lutetium Lu 177 Dotatate Administration in the Nuclear Medicine Department"

March 21, 2019 | 3:00 pm ET
Presenter: Amanda Abbott, MS, CNMT, RT(N)(CT), PET

Complimentary registration is available for SNMMI-TS Members.

Objectives:

  • Describe Peptide Receptor Radionuclide Therapy and the clinical indications for 177Lu-DOTATATE

  • Discuss patient preparation and dosing guidelines

  • Describe procedures for implementing 177Lu-DOTATATE therapy into a nuclear medicine department

Sold out.


1.0 VOICE Credit Available.